Bulk Manufacturer of Controlled Substances Application: Arista Biologicals, 41419 [2023-13466]
Download as PDF
<![CDATA[
41419
Federal Register / Vol. 88, No. 121 / Monday, June 26, 2023 / Notices
The company plans to bulk
manufacture the listed controlled
substances for the internal use
intermediates or for sale to its
customers. The company plans to
manufacture small quantities of the
above-listed controlled substances as
radiolabeled compounds for
biochemical research. No other
activities for these drug codes are
authorized for this registration.
ACTION:
Notice of application.
Arista Biologicals has applied
to be registered as a bulk manufacturer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 25, 2023. Such
persons may also file a written request
for a hearing on the application on or
before August 25, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
SUMMARY:
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–13473 Filed 6–23–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1203]
Bulk Manufacturer of Controlled
Substances Application: Arista
Biologicals
Drug Enforcement
Administration, Justice.
AGENCY:
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
In
accordance with 21 CFR 1301.33(a), this
is notice that on April 6, 2023, Arista
Biologicals, 1101 Hamilton Street,
Allentown, Pennsylvania 18101–1043,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
4-Anilino-N-Phenethyl-4-Piperidine (ANPP) ...........................................................................................................................
Norfentanyl (N-phenyl-N-(piperidin-4-yl)propionamide) ..........................................................................................................
The company plans to bulk
manufacture the listed controlled
substances for internal use as
intermediates for formulation and
analytical development purposes. No
other activities for these drug codes are
authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023–13466 Filed 6–23–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1220]
Bulk Manufacturer of Controlled
Substances Application: Olon Ricerca
Bioscience LLC
Drug Enforcement
Administration, Justice.
ddrumheller on DSK120RN23PROD with NOTICES1
AGENCY:
ACTION:
Notice of application.
Olon Ricerca Bioscience LLC,
has applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before August 25, 2023. Such
persons may also file a written request
for a hearing on the application on or
before August 25, 2023.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
SUMMARY:
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 17, 2023, Olon
Ricerca Bioscience LLC, 7528 Auburn
Road, Concord Township, Ohio 44077–
9176 applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
SUPPLEMENTARY INFORMATION:
Amphetamine .................................................................................................................................................................................
Lisdexamfetamine ..........................................................................................................................................................................
19:33 Jun 23, 2023
Jkt 259001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
II
II
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
Controlled substance
VerDate Sep<11>2014
8333
8366
Schedule
E:\FR\FM\26JNN1.SGM
26JNN1
Drug
code
Schedule
1100
1205
II
II
]]>Agencies
[Federal Register Volume 88, Number 121 (Monday, June 26, 2023)]
[Notices]
[Page 41419]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13466]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1203]
Bulk Manufacturer of Controlled Substances Application: Arista
Biologicals
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Arista Biologicals has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
August 25, 2023. Such persons may also file a written request for a
hearing on the application on or before August 25, 2023.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on April 6, 2023, Arista Biologicals, 1101 Hamilton
Street, Allentown, Pennsylvania 18101-1043, applied to be registered as
a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
4-Anilino-N-Phenethyl-4-Piperidine 8333 II
(ANPP).
Norfentanyl (N-phenyl-N-(piperidin-4- 8366 II
yl)propionamide).
------------------------------------------------------------------------
The company plans to bulk manufacture the listed controlled
substances for internal use as intermediates for formulation and
analytical development purposes. No other activities for these drug
codes are authorized for this registration.
Matthew Strait,
Deputy Assistant Administrator.
[FR Doc. 2023-13466 Filed 6-23-23; 8:45 am]
BILLING CODE P
